Medco Health Solutions Faces Second DoJ Probe In Five Years; Latest Involves AstraZeneca

Medco Health Solutions and AstraZeneca have received subpoenas from the DoJ for information involving arrangements pertaining to four AstraZeneca drugs.

More from Archive

More from Pink Sheet